Profiling gene expression using DNA arrays has had a tremendous impact on biomedical research. From a disease investigation point of view, applications of DNA microarrays include uncovering unsuspected associations between genes and specific clinical features of disease, resulting in novel, molecular-based disease classifications. Cancer is a case in point. Most published studies of cancers using DNA microarrays have either examined a pathologically homogeneous set of tumors to identify clinically relevant subtypes, for example, responders vs nonresponders, or pathologically distinct subtypes of cancer of the same lineage, for example, highstage vs low-stage tumors to identify molecular correlates, or tumors of different lineages to identify molecular signatures for each lineage. A study of cutaneous T-cell lymphoma by Kari et al, 1 published recently, typifies both what one hopes to gain from disease investigations using DNA microarrays and the limitations of such studies.
Primary cutaneous lymphomas are a heterogeneous group of lymphomas of T-or B-cell origin that represent a relatively common type of lymphoma and their incidence appears to be increasing. The two predominant subtypes of cutaneous T-cell lymphomas are mycosis fungoides, a mostly indolent variety, and its leukemic counterpart the Sezary syndrome, an aggressive variety characterized by skin involvement, lymphadenopathy and circulating atypical lymphocytes, the so-called Sezary cells. Kari et al used cDNA microarrays to study gene expression patterns in peripheral blood mononuclear cells from patients with the leukemic form of cutaneous T-cell lymphoma. The goal of the study was to identify markers that may be useful for diagnosis or prognosis, or that might provide new targets for treating this disease. The approach was to uncover gene expression differences between cells from 18 patients with high Sezary cell counts and an appropriate (Th2-skewed) cell fraction from nine normal controls. The differences in gene expression observed reflected many of the observed characteristics of the disease. Overexpressed genes in disease samples included some genes required for Th2 differentiation characteristic of Sezary cells. The analysis, however, did not uncover changes consistent with the hypothesis of defective apoptotic pathways in this disease. An important objective of the study was to identify markers for cutaneous Tcell lymphoma given the paucity of such markers. A member of the plastin gene family and a chemokine (CX3CR1) inappropriately expressed represented such potential novel markers. Two genes found to have a high predictive power to classify patients and controls were STAT4 and GTPase RhoB. These two genes alone accurately classified the high Sezary cell patients and controls. A signature profile with 10 genes was uncovered that identified a class of patients who succumb to the disease early, irrespective of their tumor burden. The study therefore uncovered a wealth of findings that shed some light on the biology of this disease and uncovered markers that may have a practical utility.
The DNA microarray studies described above and others in the literature indeed point to the great utility of DNA microarrays for uncovering patterns of gene expression that are clinically informative. Have the data been thoroughly analyzed? There is no shortage of analytical tools for uncovering patterns in microarray data. An important challenge for microarray analysis is to understand at a mechanistic level the significance of associations observed between subsets of genes and clinical features of disease. Another challenge is to identify the smallest but most informative sets of genes associated with specific clinical features, which then could be interrogated using technologies available in clinical laboratories, as appears to have been accomplished in this study. Another challenge is to determine how well RNA levels of predictive genes correlate with protein levels. A lack of correlation may imply that the predictive property of the gene(s) is independent of gene function.
To increase the effectiveness of DNA microarray analysis, global gene expression data may be combined with external data sources, such as gene annotation, in order to associate the expression patterns of a set of genes with the biological processes that they may represent. A welcome trend of data sharing allows others to analyze previously published microarray data and to combine multiple data sets. For illustration, we examined the data set published by Kari et al to see what we could uncover. In our analysis, we relied on the Gene Ontology (GO) annotation. The Gene Ontology Consortium 2 has defined a controlled vocabulary for describing genes in terms of their molecular function, participation in biological processes and cellular locations. The GO annotations are making possible the highthroughput analyses of gene expression in terms of functional gene class associations, which otherwise would require laborious and somewhat subjective manual literature searches.
Using the data set from Kari et al, we searched a set of 122 genes found overexpressed in patients with high blood tumor burden, or Sezary cell count, compared to healthy controls (Po0.01, fold change 41.5), for significantly enriched (over-represented) GO terms, as described elsewhere. 3 We made the same search for a set of 280 genes found underexpressed in patients with high Sezary cell count (Po0.01, fold change o0.67). Our premise is that annotation terms that are shared by a significant number of genes within a large gene set may provide clues as to the processes driving the coordinate expression of the genes as a whole. Numerous enriched terms were found for the set of 280 underexpressed genes with Po0.001, including class II major histocompatibility complex antigen (five genes represented), cytokine-binding activity (six), mitochondrion (26), electron transporter activity (12) and nucleotide metabolism (four); these enriched terms could suggest a downregulation in CTCL of processes related to the immune response and mitochondrial function. Terms found enriched for the set of 122 overexpressed genes with Po0.05 include cell adhesion (nine genes represented) and cell cycle arrest (three).
The enriched GO terms listed above represent only a fraction of the genes significantly expressed in CTCL, and additional gene-to-process associations, not currently described in the biomedical literature or public annotation sources, may be inferred from data mining of large expression profile data sets. Our premise in this case is that genes that are coordinately expressed participate in closely related biological processes. 4 For a given gene, a GO term may be associated if the gene is correlated in expression with a significant number of other genes that share the given GO term annotation. We examined the expression patterns of 60 genes highly underexpressed in the Kari et al data set for patients with high Sezary cell count (Po0.01, fold change o0.33) that were also represented in a large independent data set of leukemia expression profiles from Armstrong et al. 5 For each of the 60 genes, the set of genes with significant positive correlations (Po0.01) with the given gene in the Armstrong data set was searched for significantly enriched GO terms (Po0.0001). In this way, 1963 gene-to-term associations, involving all 60 genes, were found. We performed two simulation tests to assess the number of random gene-toterm associations that could exist in the Armstrong data set, in one test permuting the expression values and Figure 1 Hierarchical clustering of associations of GO terms for genes found underexpressed in patients with high Sezary cell count (Po0.01, fold change o0.33). For each gene-to-term association represented here, the given gene was found positively correlated in expression with a significant number of other genes that share the given GO term annotation. The rows in the matrix diagram represent genes; the columns represent terms. An entry in the matrix indicates that the corresponding gene-to-term association was found in the leukemia profile data set from Armstrong et al with Po0.0001. Three major clusters are highlighted corresponding to terms related to (1) intercellular signaling, (2) the immune response, and (3) cell proliferation. Table 1 lists the genes that fall under each cluster.
in another test permuting the annotation assignments. Neither search with these randomized data sets yielded more than 15 associations, indicating that most of the actual associations found were not the result of chance.
We used average linkage hierarchical clustering 4 to obtain a global view of the gene-to-term associations mined from the Armstrong leukemia expression data set. Figure 1 shows the resulting cluster diagram (with 113 GO terms that were associated with at least five genes being represented and with 49 genes that were associated with at least one of these terms). Genes are represented in the rows of the matrix diagram, and terms are represented in the columns. An entry in the diagram indicates that the given gene (underexpressed in patients with high Sezary count compared to healthy controls) was coexpressed with a significant number of genes that share the given annotation term. GO terms that are closely related to each other by the biological concepts that they represent were found to cluster together. The clustering diagram defines three distinct major clusters of genes and terms related to intercellular signaling (labeled as Cluster '1' in the figure) , the immune response (labeled Cluster '2'), and cell proliferation (labeled Cluster '3'). Table 1 lists the genes that fall under each cluster, with example terms.
Our GO term clustering analysis indicates that many of the genes underexpressed in CTCL may be associated with processes of cell proliferation, the immune response or intercellular signaling, which suggests a hypothesis that the pathogenesis of CTCL involves a downregulation of these processes. CTCL is characterized by the accumulation of malignant cells with a low proliferative index, which appears consistent with the observation made here of numerous genes associated with proliferation being underexpressed in CTCL. The observed underexpression in CTCL of numerous genes involved in the immune response, including several genes encoding for the class II major histocompatibility antigen complex, might be construed as contradicting one hypothesis that CTCL may be a malignancy of T cells stimulated to proliferate against its own tumor antigens. 6 There has been much speculation that CTCL cells are defective in their apoptotic pathways, and that the disease is linked to an accumulation rather than a true proliferation of T cells. 7 Underexpressed genes in CTCL thought to mediate apoptosis, including STAT4, CTSL (cathepsin L), IL1R1 (interleukin 1 receptor, type I) and TNFAIP6 (tumor necrosis factor, alphainduced protein 6), are associated here with intercellular signaling-related terms.
However perfected DNA microarrays and their analytical tools become for disease profiling, they will not eliminate a pressing need for other types of profiling technologies that go beyond measuring RNA levels, particularly for disease-related investigations. DNA microarrays have limited utility for the analysis of biological fluids and for uncovering directly in the fluid, assayable biomarkers. There is a need to assay protein levels and activity. Numerous alterations may occur in proteins that are not reflected in changes at the RNA level, providing a compelling rationale for additional, direct analysis of gene expression at the protein level. The next challenge is to integrate RNA data with protein data.
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